News on AVI BioPharma from BioPortfolio.com http://www.BioPortfolio.com Consolidated AVI BioPharma news from BioPortfolio.com Wed, 10 Feb 2010 11:36:40 GMT en AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040716&HITNO=0&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040716&THISHREF=http://c.moreover.com/click/here.pl%3fz2538850339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040716&HITNO=0&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040716&THISHREF=http://c.moreover.com/click/here.pl%3fz2538850339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: Avi obtains European orphan drug designation for genetic disorder drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034957&HITNO=1&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034957&THISHREF=http://c.moreover.com/click/here.pl%3fz2536067818%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034957&HITNO=1&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034957&THISHREF=http://c.moreover.com/click/here.pl%3fz2536067818%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: AVI BioPharma's drug candidate for Duchenne Muscular Dystrophy gets orphan drug designation from EMEAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034664&HITNO=2&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034664&THISHREF=http://c.moreover.com/click/here.pl%3fz2535915170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034664&HITNO=2&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034664&THISHREF=http://c.moreover.com/click/here.pl%3fz2535915170%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: AVI BioPharmas Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028199&HITNO=3&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028199&THISHREF=http://c.moreover.com/click/here.pl%3fz2532626364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028199&HITNO=3&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028199&THISHREF=http://c.moreover.com/click/here.pl%3fz2532626364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026584&HITNO=4&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026584&THISHREF=http://c.moreover.com/click/here.pl%3fz2530988732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026584&HITNO=4&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026584&THISHREF=http://c.moreover.com/click/here.pl%3fz2530988732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026830&HITNO=5&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026830&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026830&HITNO=5&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026830&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Medical News: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrophyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026538&HITNO=6&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026538&THISHREF=http://c.moreover.com/click/here.pl%3fz2530932972%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026538&HITNO=6&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026538&THISHREF=http://c.moreover.com/click/here.pl%3fz2530932972%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023927&HITNO=7&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023927&THISHREF=http://c.moreover.com/click/here.pl%3fz2528489590%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023927&HITNO=7&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023927&THISHREF=http://c.moreover.com/click/here.pl%3fz2528489590%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: AVI BioPharma's AVI-5038 receives European orphan drug designationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024417&HITNO=8&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024417&THISHREF=http://c.moreover.com/click/here.pl%3fz2528876390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024417&HITNO=8&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024417&THISHREF=http://c.moreover.com/click/here.pl%3fz2528876390%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025339&HITNO=9&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025339&THISHREF=http://c.moreover.com/click/here.pl%3fz2529672015%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4025339&HITNO=9&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4025339&THISHREF=http://c.moreover.com/click/here.pl%3fz2529672015%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020775&HITNO=10&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020775&THISHREF=http://c.moreover.com/click/here.pl%3fz2526996696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020775&HITNO=10&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020775&THISHREF=http://c.moreover.com/click/here.pl%3fz2526996696%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscuhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020705&HITNO=11&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020705&THISHREF=http://c.moreover.com/click/here.pl%3fz2526966409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020705&HITNO=11&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020705&THISHREF=http://c.moreover.com/click/here.pl%3fz2526966409%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020669&HITNO=12&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020669&THISHREF=http://c.moreover.com/click/here.pl%3fz2526941585%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020669&HITNO=12&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020669&THISHREF=http://c.moreover.com/click/here.pl%3fz2526941585%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020622&HITNO=13&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020622&THISHREF=http://c.moreover.com/click/here.pl%3fz2526889892%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020622&HITNO=13&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020622&THISHREF=http://c.moreover.com/click/here.pl%3fz2526889892%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire via MSN Money: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020591&HITNO=14&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020591&THISHREF=http://c.moreover.com/click/here.pl%3fz2526860095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020591&HITNO=14&MSIZE=69&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=AVI%20BioPharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020591&THISHREF=http://c.moreover.com/click/here.pl%3fz2526860095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: